Literature DB >> 968356

Chloroquine: a review.

A J Popert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 968356     DOI： 10.1093/rheumatology/15.3.235

Source DB:  PubMed          Journal:  Rheumatol Rehabil        ISSN： 0300-3396


× No keyword cloud information.
  13 in total

1.  Electrochemical Response of Redox Amino Acid Encoded Fluorescence Protein for Hydroxychloroquine Sensing.

Authors:  Asuma Janeena; Narayanan Jayaraman; Ganesh Shanmugam; Shanmugam Easwaramoorthi; Niraikulam Ayyadurai
Journal:  Appl Biochem Biotechnol       Date:  2022-10-19       Impact factor: 3.094

Review 2.  Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine.

Authors:  Mariana Babayeva; Zvi Loewy
Journal:  Pharmgenomics Pers Med       Date:  2020-10-23

3.  Nitrogen mustard in severe rheumatoid arthritis.

Authors:  R Kitt; D L Scott; B L Coulton; A J Popert
Journal:  Clin Rheumatol       Date:  1983-03       Impact factor: 2.980

Review 4.  Rethinking the role of hydroxychloroquine in the treatment of COVID-19.

Authors:  Eric A Meyerowitz; Augustin G L Vannier; Morgan G N Friesen; Sara Schoenfeld; Jeffrey A Gelfand; Michael V Callahan; Arthur Y Kim; Patrick M Reeves; Mark C Poznansky
Journal:  FASEB J       Date:  2020-04-29       Impact factor: 5.191

5.  Use of hydroxychloroquine and interferon alpha-2b for the prophylaxis of COVID-19.

Authors:  Alexander Yang; Charlotte Yang; Bing Yang
Journal:  Med Hypotheses       Date:  2020-05-20       Impact factor: 1.538

6.  Chloroquine, the Coronavirus Crisis, and Neurodegeneration: A Perspective.

Authors:  Giona Pedrioli; Rickie Patani; Paolo Paganetti
Journal:  Front Neurol       Date:  2020-11-13       Impact factor: 4.003

Review 7.  SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings.

Authors:  Rajkumar Singh Kalra; Dhanendra Tomar; Avtar Singh Meena; Ramesh Kandimalla
Journal:  Pathogens       Date:  2020-07-07

8.  Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.

Authors:  Jia Liu; Ruiyuan Cao; Mingyue Xu; Xi Wang; Huanyu Zhang; Hengrui Hu; Yufeng Li; Zhihong Hu; Wu Zhong; Manli Wang
Journal:  Cell Discov       Date:  2020-03-18       Impact factor: 10.849

Review 9.  A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2.

Authors:  Alexander Simonis; Sebastian J Theobald; Gerd Fätkenheuer; Jan Rybniker; Jakob J Malin
Journal:  EMBO Mol Med       Date:  2020-11-03       Impact factor: 12.137

Review 10.  Drug repurposing approach to fight COVID-19.

Authors:  Thakur Uttam Singh; Subhashree Parida; Madhu Cholenahalli Lingaraju; Manickam Kesavan; Dinesh Kumar; Raj Kumar Singh
Journal:  Pharmacol Rep       Date:  2020-09-05       Impact factor: 3.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.